By a News Reporter-Staff News Editor at Preventive Medicine Week -- Investigators publish new report on Immune System Diseases and Conditions - HIV/AIDS. According to news originating from New York City, New York, by NewsRx correspondents, research stated, “Oral pre-exposure prophylaxis (PrEP) is highly effective at reducing HIV transmission risk and is CDC recommended for many gay, bisexual, and other men who have sex with men (GBM). We sought to investigate awareness of and preference for using long-acting injectable PrEP (LAI-PrEP) among GBM currently taking oral PrEP (n = 104), and identify their concerns.”
Financial support for this research came from National Institute of Drug Abuse.
Our news journalists obtained a quote from the research from the City University of New York, “About half of GBM had heard of LAI-PrEP, and 30.8% specifically preferred LAI-PrEP. GBM with more concerns about the level of protection and drug half-life of LAI-PrEP had lower odds of preferring LAI-PrEP.”
According to the news editors, the research concluded: “Given that daily pill adherence is a challenge for some on PrEP, it is important to investigate the degree to which those on PrEP might consider LAI-PrEP as an alternative.”
For more information on this research see: Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available? AIDS and Behavior , 2018;22(4):1184-1189. AIDS and Behavior can be contacted at: Springer, Plenum Publishers, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; AIDS and Behavior - http://www.springerlink.com/content/1090-7165/)
The news correspondents report that additional information may be obtained from C. Grov, CUNY, Grad Sch Public Hlth & Hlth Policy, New York, NY 10027, United States. Additional authors for this research include T.H.F. Whitfield, H.J. Rendina, J.T. Parsons and S.A. John.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10461-017-1907-2. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-05-06), Findings from City University of New York Yields New Data on HIV/AIDS [Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?], Preventive Medicine Week, 12, ISSN: 1547-8580, BUTTER® ID: 015571756
From the newsletter Preventive Medicine Week.
https://www.newsrx.com/Butter/#!Search:a=15571756
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.